BEDMINSTER, N.J.--(BUSINESS WIRE)--EKR Therapeutics, Inc., a privately held specialty pharmaceutical company focused on providing critical care products to the hospital marketplace, has announced that Rolf A. Classon has joined the Company as Chairman of the Board.
